[link removed]
[link removed] [link removed]
View this email in your browser ([link removed])
BREAKING NEWS ALERT
Johnson & Johnson’s one-shot COVID-19 vaccine appears to provide more protection against worrisome virus variants than the drug giant initially reported, according to new trial data released in advance of a Friday advisory panel meeting on whether to recommend the vaccine as the third cleared for emergency use in the US.

Company briefing documents posted on the Food and Drug Administration website Wednesday indicate the vaccine was 68 percent effective at preventing moderate to severe disease caused by the dominant variant in Brazil and 64 percent effective against the dominant variant in South Africa.

Read the full story on BostonGlobe.com ([link removed]) .

Related: COVID-19 vaccine news, resources, and guidance ([link removed])
Subscribe to BostonGlobe.com ([link removed])
------------------------------------------------------------
We have lots of e-mail newsletters on a variety of topics, including news, politics, business, sports, lifestyle, and more. They're free, and it's easy to subscribe. Here's a complete list. ([link removed])
------------------------------------------------------------
[link removed]
[link removed] [link removed]

============================================================
** Like us ([link removed])
** Follow us ([link removed])
You received this message because you signed up for Breaking News Alerts.

Copyright © 2021 The Boston Globe, All rights reserved.

Our mailing address is:
The Boston Globe
1 Exchange Place Suite 201
Boston, MA 02109-2132
USA

** unsubscribe from this list ([link removed])

** Manage Your Account ([link removed])
| ** Terms of Service ([link removed])
| ** Privacy Policy ([link removed])
| ** Help Center ([link removed])
| ** Advertise (mailto:[email protected]?subject=Advertising+in+BostonGlobe.com)